Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chastang

Showing results (241-250 of 249) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 249 results.
European Journal of Cancer|October 1, 1975
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up)C Jacquillat, M Weil, G Auclerc, et al.
Blood|October 9, 1998
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL GroupS De Botton, H Dombret, M Sanz, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|May 29, 2003
Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trialM Marre, J Garcia Puig, F Kokot, et al.
Bone Marrow Transplantation|May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study GroupF Guilhot, A Guerci, D Fiere, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combinationR G Asmar, G M London, M E O'Rourke, et al.
Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Leukemia|April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseF Maloisel, A Guerci, D Guyotat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative GroupJ M Tourani, C Pfister, J F Berdah, et al.
Pageof 25

Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
European Journal of Cancer|October 1, 1975
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up)C Jacquillat, M Weil, G Auclerc, et al.
Blood|October 9, 1998
Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL GroupS De Botton, H Dombret, M Sanz, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|May 29, 2003
Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trialM Marre, J Garcia Puig, F Kokot, et al.
Bone Marrow Transplantation|May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study GroupF Guilhot, A Guerci, D Fiere, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|February 19, 2002
Amelioration of arterial properties with a perindopril-indapamide very-low-dose combinationR G Asmar, G M London, M E O'Rourke, et al.
Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.
Blood|July 1, 1996
Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long-term study of 71 patients Société Française de Greffe de MoelleL Sutton, C Chastang, P Ribaud, et al.
Leukemia|April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phaseF Maloisel, A Guerci, D Guyotat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative GroupJ M Tourani, C Pfister, J F Berdah, et al.
Pageof 25